In a 37‑week pregnant woman presenting with mild headache and nausea, what is the appropriate evaluation and management?

Immediate Blood Pressure Assessment and Preeclampsia Evaluation Required

A 37-week pregnant woman with mild headache and nausea requires urgent blood pressure measurement and evaluation for preeclampsia with severe features, as delivery is recommended at this gestational age if preeclampsia is confirmed 1.

Critical Initial Assessment

At 37 weeks gestation, these symptoms are concerning for preeclampsia until proven otherwise. You must immediately:

• Measure blood pressure – Look for BP ≥140/90 mm Hg (diagnostic threshold for hypertensive disorders of pregnancy per current guidelines) 1
• Check for severe features – BP ≥160/110 mm Hg, persistent severe headache, visual changes, right upper quadrant pain, altered mental status
• Obtain urinalysis – Assess for proteinuria (≥2+ on dipstick warrants quantification)
• Order laboratory workup – Complete blood count (platelets), liver enzymes (AST/ALT), creatinine, uric acid 2

Management Algorithm Based on Findings

If Preeclampsia Confirmed (BP ≥140/90 + proteinuria or end-organ dysfunction):

Deliver at 37 weeks – This is the definitive treatment per current guidelines, as continued observation is only reasonable before 37 weeks 1. The risk-benefit calculation shifts dramatically at term.

• If severe features present (BP ≥160/110 or persistent severe headache):
  • Initiate IV magnesium sulfate for seizure prophylaxis 1
  • Treat severe hypertension acutely with IV labetalol (10-20 mg bolus, repeat 20-80 mg every 10-20 minutes, max 300 mg) as first-line 3
  • Alternative: IV hydralazine (5 mg bolus, repeat 5-10 mg every 20 minutes) though associated with more maternal hypotension and requires closer monitoring 3
  • Proceed to delivery

If Blood Pressure Normal or Mildly Elevated Without Preeclampsia Features:

Do not dismiss the headache – Persistent or unusual headaches, especially with focal neurological symptoms, require neuroimaging to exclude secondary intracranial causes 2, 4.

• Perform focused neurological examination looking for:

  • Focal deficits (weakness, sensory changes, visual field defects)
  • Papilledema on fundoscopy
  • Abnormal reflexes (Babinski sign) 2

• If neurological examination is abnormal: Obtain brain MRI (preferred in pregnancy) or CT if MRI unavailable 4. Nearly 20% of pregnant women with headache and abnormal neurological findings have pathological imaging (cerebral venous thrombosis, posterior reversible encephalopathy syndrome, intracranial hemorrhage, or rarely obstructive hydrocephalus) 2, 4.

• If examination is normal and symptoms are mild: Consider primary headache (migraine most common in pregnancy) 5. Treat with acetaminophen as first-line; triptans are second-line and preferred over butalbital combinations 5.

Critical Pitfalls to Avoid

Do not assume preeclampsia explains all symptoms – The case report of obstructive hydrocephalus masquerading as impending eclampsia at 37 weeks demonstrates that coexisting intracranial pathology can be missed when hypertension and proteinuria are present 2. Any persistent headache despite blood pressure control or delivery warrants neuroimaging.

Do not use short-acting oral nifedipine for acute severe hypertension – This can cause uncontrolled hypotension and fetal compromise, particularly when combined with magnesium sulfate 3. IV labetalol is safer and more controllable.

Do not delay delivery at 37 weeks if preeclampsia is confirmed – The guidelines are clear that delivery is recommended at this gestational age, as the risks of expectant management outweigh benefits at term 1.

Nuance in the Evidence

The 2025 Circulation guidelines 1 emphasize that treatment thresholds differ between guideline organizations, but there is consensus that at ≥37 weeks with preeclampsia, delivery is appropriate. The European guidelines 3 provide more granular detail on acute antihypertensive management, with IV labetalol emerging as the preferred agent over hydralazine due to better safety profile. The odds of abnormal neuroimaging are 2.2 times higher when neurological examination is abnormal 4, making the focused neurological exam a critical triage tool.